Baxter Aktiengesellschaft
Industry / private company
Location:
Wien,
Austria (AT)
ISNI: 000000449113591
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. (2020)
Weidner L, Gaensdorfer S, Unterweger S, Weseslindtner L, Drexler C, Farcet M, Witt V, et al.
Journal article
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies (2016)
Borte M, Krivan G, Derfalvi B, Marodi L, Harrer T, Jolles S, Bourgeois C, et al.
Journal article